Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|August 18, 2009
Discovery of 4H-pyrazolo[1,5-a]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymeraseYongqi Deng, Gerald W Shipps, Tong Wang, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Aminothiazole inhibitors of HCV RNA polymeraseGerald W Shipps, Yongqi Deng, Tong Wang, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymeraseJaneta Popovici-Muller, Gerald W Shipps, Kristin E Rosner, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1)Yongqi Deng, Zhiwei Yang, Gerald W Shipps, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2021
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffoldWensheng Yu, Yongqi Deng, David Sloman, et al.
Journal of Medicinal Chemistry|October 15, 2014
Discovery of novel, dual mechanism ERK inhibitors by affinity selection screening of an inactive kinaseYongqi Deng, Gerald W Shipps, Alan Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitorYongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer ImmunotherapyHongjun Zhang, Kun Liu, Qinglin Pu, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2021
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitorsWensheng Yu, Yongqi Deng, Brett Hopkins, et al.
Pageof 4